Chheda Pratiksha, Dama Tavisha, Goradia Dollar, Pande Shailesh, Vinarkar Sushant
a Department of Molecular Pathology , Metropolis Healthcare Ltd. , Mumbai , India.
b Department of Genetics , Metropolis Healthcare Ltd. , Mumbai , India.
Fetal Pediatr Pathol. 2018 Dec;37(6):448-451. doi: 10.1080/15513815.2018.1532473. Epub 2018 Dec 27.
Cystic fibrosis (CF) is a genetic disease usually diagnosed by clinical findings and abnormal sweat chloride testing.
We report a case of an 18-month-old Indian female with clinical findings suggestive of CF referred for genetic confirmation. The CFTR gene was sequenced for 23 mutations as per American College of Medical Genetics (ACMG) guidelines for CF and showed presence of a known common heterozygous delF508 (c.1521_1523delCTT, p.Phe508 del) variant. In addition to delF508 variant, exon 10 of CFTR gene also showed a novel variant c.1551C > G, p.Tyr517*, which was classified as "likely pathogenic" based on recent ACMG variant classification guidelines. The presence of compound heterozygous pathogenic variants along with classical clinical findings, confirmed the diagnosis of CF in this patient.
The novel pathogenic variants (missense/nonsense/deletion/duplication) in CFTR gene are often identified and are associated with CF, thus highlighting the need of comprehensive complete CFTR gene analysis.
囊性纤维化(CF)是一种遗传性疾病,通常通过临床表现和异常的汗液氯化物检测来诊断。
我们报告一例18个月大的印度女性病例,其临床表现提示患有CF,前来进行基因确诊。按照美国医学遗传学学会(ACMG)关于CF的指南,对CFTR基因进行了23种突变的测序,结果显示存在一种已知的常见杂合缺失F508(c.1521_1523delCTT,p.Phe508 del)变异。除了delF508变异外,CFTR基因的第10外显子还显示出一种新的变异c.1551C>G,p.Tyr517*,根据最近的ACMG变异分类指南,该变异被归类为“可能致病”。复合杂合致病变异的存在以及典型的临床表现,证实了该患者患有CF。
CFTR基因中的新型致病变异(错义/无义/缺失/重复)经常被发现,且与CF相关,因此凸显了对CFTR基因进行全面完整分析的必要性。